Hemin for injection ( DrugBank: Hemin )
1 disease
告示番号 | 疾患名(ページ内リンク) | 臨床試験数 |
---|---|---|
254 | ポルフィリン症 | 1 |
254. ポルフィリン症
臨床試験数 : 72 / 薬物数 : 53 - (DrugBank : 16) / 標的遺伝子数 : 19 - 標的パスウェイ数 : 35
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02922413 (ClinicalTrials.gov) | October 30, 2015 | 1/1/2016 | Panhematin for Prevention of Acute Attacks of Porphyria | Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria | Acute Intermittent Porphyria;Hereditary Coproporphyria;Variegate Porphyria | Biological: Hemin for injection;Other: Placebo | The University of Texas Medical Branch, Galveston | NULL | Recruiting | 18 Years | N/A | All | 20 | Phase 2 | United States |